NCT02430688View on ClinicalTrials.gov

Irreversible Electroporation(IRE) For Unresectable Extremities Neoplasms

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

December 1, 2020

Study Completion Date

February 1, 2021

Conditions
Extremities Neoplasms
Interventions
PROCEDURE

Irreversible electroporation (IRE)

DEVICE

NanoKnife

Trial Locations (1)

510000

Biological treatment center in Fuda cancer hospital, Guangzhou

All Listed Sponsors
lead

Fuda Cancer Hospital, Guangzhou

OTHER

NCT02430688 - Irreversible Electroporation(IRE) For Unresectable Extremities Neoplasms | Biotech Hunter | Biotech Hunter